Acadia Healthcare (NASDAQ:ACHC) Hits New 1-Year Low – What’s Next?

Acadia Healthcare Company, Inc. (NASDAQ:ACHC)’s stock price hit a new 52-week low during trading on Tuesday . The company traded as low as $12.50 and last traded at $12.64, with a volume of 1387869 shares changing hands. The stock had previously closed at $13.23.

Analyst Upgrades and Downgrades

Several equities analysts have recently weighed in on ACHC shares. UBS Group cut their target price on Acadia Healthcare from $28.00 to $24.00 and set a “buy” rating on the stock in a research report on Wednesday, December 3rd. Leerink Partnrs cut shares of Acadia Healthcare from a “strong-buy” rating to a “hold” rating in a research report on Wednesday, December 3rd. KeyCorp lowered their target price on shares of Acadia Healthcare from $30.00 to $25.00 and set an “overweight” rating for the company in a report on Wednesday, December 3rd. Cantor Fitzgerald set a $17.00 price target on shares of Acadia Healthcare in a research note on Wednesday, December 3rd. Finally, Guggenheim reduced their price objective on shares of Acadia Healthcare from $29.00 to $27.00 and set a “buy” rating on the stock in a research report on Monday, November 10th. Seven investment analysts have rated the stock with a Buy rating, six have issued a Hold rating and two have given a Sell rating to the company’s stock. According to data from MarketBeat.com, the stock currently has an average rating of “Hold” and a consensus target price of $18.82.

Acadia Healthcare Stock Down 5.1%

The company has a market cap of $1.16 billion, a P/E ratio of 10.73, a price-to-earnings-growth ratio of 3.55 and a beta of 0.88. The company has a debt-to-equity ratio of 0.73, a quick ratio of 1.44 and a current ratio of 1.44. The business’s fifty day moving average is $15.44 and its two-hundred day moving average is $20.23.

Acadia Healthcare (NASDAQ:ACHC) last issued its earnings results on Wednesday, November 5th. The company reported $0.72 EPS for the quarter, topping analysts’ consensus estimates of $0.71 by $0.01. The business had revenue of $851.57 million for the quarter, compared to analyst estimates of $852.43 million. Acadia Healthcare had a net margin of 3.29% and a return on equity of 7.66%. The company’s quarterly revenue was up 4.4% compared to the same quarter last year. During the same period last year, the company posted $0.91 earnings per share. Acadia Healthcare has set its FY 2025 guidance at 2.350-2.450 EPS. Equities analysts predict that Acadia Healthcare Company, Inc. will post 3.38 EPS for the current year.

Hedge Funds Weigh In On Acadia Healthcare

Institutional investors have recently bought and sold shares of the business. Envestnet Portfolio Solutions Inc. boosted its stake in Acadia Healthcare by 256.4% in the second quarter. Envestnet Portfolio Solutions Inc. now owns 26,053 shares of the company’s stock valued at $591,000 after acquiring an additional 18,742 shares in the last quarter. Oppenheimer Asset Management Inc. lifted its holdings in shares of Acadia Healthcare by 85.1% during the 2nd quarter. Oppenheimer Asset Management Inc. now owns 28,683 shares of the company’s stock valued at $651,000 after purchasing an additional 13,188 shares during the last quarter. Janney Montgomery Scott LLC acquired a new stake in shares of Acadia Healthcare in the 2nd quarter worth $479,000. Caxton Associates LLP grew its stake in Acadia Healthcare by 1,234.5% during the 2nd quarter. Caxton Associates LLP now owns 173,482 shares of the company’s stock worth $3,936,000 after buying an additional 160,482 shares during the last quarter. Finally, Truist Financial Corp increased its position in Acadia Healthcare by 85.6% during the 2nd quarter. Truist Financial Corp now owns 82,741 shares of the company’s stock valued at $1,877,000 after buying an additional 38,167 shares in the last quarter.

Acadia Healthcare Company Profile

Acadia Healthcare Company, Inc (NASDAQ: ACHC) is a publicly traded provider of behavioral healthcare services headquartered in Franklin, Tennessee. Founded in 2005, the company has grown through organic expansion and strategic acquisitions to establish itself as a leading specialist in mental health and addiction treatment across the United States.

Acadia operates a diversified network of inpatient psychiatric hospitals, residential treatment centers, outpatient clinics and intensive outpatient programs.